{"id":"bb587f7f-3517-42cd-b9ab-62413666ed7a","kind":"news","code":"bb587f7f-3517-42cd-b9ab-62413666ed7a","name":"Yunhe Pharma Secures Equity Investment","nameBasis":"translated-title","summary":"On September 22, 2026, Suzhou-based Yunhe Zhiyao, a biopharmaceutical developer, completed an equity investment from Guanghua Wutong, Xiaochi Capital, Wutong Juyun and Ruishang Pharma.","description":"","country":null,"category":null,"originalName":"云合智药完成股权投资融资","eventDate":"2026-09-22T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-19T21:00:18.321Z","englishUpdatedAt":"2026-10-20T18:21:32.462Z","reviewedAt":"2026-10-20T18:21:32.462Z","snapshotAt":"2026-10-20T18:19:32.670Z","sourceHash":"ea066dd0782e5410d6d03df74200e66b585faf55fabe79ec7886add95a07ef49","companyId":"99a0fd50-4f26-4248-8b43-9215dfb34f1d","foundedYear":null,"logoUrl":null,"originalText":"2026年9月22日，据公开报道，苏州生物医药研发商云合智药完成股权投资，光华梧桐、晓池资本、梧桐聚云企管、瑞尚医药参与。公司专注生物医药研发。","sources":[],"related":[{"id":"9caef666-9303-4702-b315-dcd287860601","kind":"institutions","code":"UB-I2569","name":"Guanghuawutong","nameBasis":"transliterated","summary":"Guanghuawutong, a venture capital firm focused on technology investments.","description":"Guanghuawutong, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"光华梧桐","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:30:24.511Z","englishUpdatedAt":"2026-10-15T17:35:39.482Z","reviewedAt":"2026-10-15T17:35:39.482Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"13863f03814d89b1ea55192a10f84868abc595d877a9febc75fdb06a7104dc2c","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/guanghuawutong"},{"id":"77f3a2be-b7a0-4f10-af8c-b556cb062f38","kind":"institutions","code":"UB-I2594","name":"Ruishang Pharmaceutical","nameBasis":"transliterated","summary":"Ruishang Pharmaceutical, a corporate investment entity undertaking strategic investments.","description":"Ruishang Pharmaceutical, a corporate investment entity undertaking strategic investments.","country":null,"category":null,"originalName":"瑞尚医药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:30:24.716Z","englishUpdatedAt":"2026-10-15T17:35:39.247Z","reviewedAt":"2026-10-15T17:35:39.247Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"7fb331827278d64a568c714321ba30d3af38f1de8c67065bb152ed9ca6fe502a","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/ruishang-pharmaceutical"},{"id":"10487823-cb05-4bbb-a471-ef138630a216","kind":"institutions","code":"UB-I2629","name":"Wutongjuyunqiguan","nameBasis":"transliterated","summary":"Wutongjuyunqiguan, an investment firm.","description":"Wutongjuyunqiguan, an investment firm.","country":null,"category":null,"originalName":"梧桐聚云企管","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:30:25.041Z","englishUpdatedAt":"2026-10-15T17:35:38.601Z","reviewedAt":"2026-10-15T17:35:38.601Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"99fa9d6c164534ab4dbd997253e09a3dcb3394007e493769f63b71c639492a1d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/wutongjuyunqiguan"},{"id":"28aa9215-44bf-4612-8289-5ea3c2dd5dff","kind":"institutions","code":"UB-I2654","name":"Xiaochi Capital","nameBasis":"transliterated","summary":"Xiaochi Capital, a venture capital firm focused on technology investments.","description":"Xiaochi Capital, a venture capital firm focused on technology investments.","country":null,"category":null,"originalName":"晓池资本","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:30:25.315Z","englishUpdatedAt":"2026-10-15T17:35:38.732Z","reviewedAt":"2026-10-15T17:35:38.732Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"366aa91657cafdef05780cf5e9c0a63542ba6c34c052ea5c91604243ed0def0d","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/institutions/xiaochi-capital"},{"id":"99a0fd50-4f26-4248-8b43-9215dfb34f1d","kind":"companies","code":"UB-C6135","name":"Yunhezhiyao","nameBasis":"transliterated","summary":"AI target discovery, RNA sequence optimization, and small nucleic acid drug development","description":"","country":"China","category":null,"originalName":"云合智药","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-08T00:00:00.000Z","englishUpdatedAt":"2026-10-20T18:25:26.421Z","reviewedAt":"2026-10-20T18:25:26.421Z","snapshotAt":"2026-10-20T18:05:01.520Z","sourceHash":"542ca6bd8a4a26fb20c39dc32ccb49e448e0571747be590c47db5814626617fd","companyId":null,"foundedYear":null,"logoUrl":null,"path":"/companies/UB-C6135"}],"path":"/news/bb587f7f-3517-42cd-b9ab-62413666ed7a","structured":{"city":null,"country":null,"location":null,"role":null,"category":null,"company":{"name":"Yunhezhiyao","path":"/companies/UB-C6135"}},"canonical":"https://uniquebase.ai/news/bb587f7f-3517-42cd-b9ab-62413666ed7a"}